Patents by Inventor Dennis Triglia

Dennis Triglia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of producing C3A serum-free clonal cell line
    Patent number: 8715954
    Abstract: A serum-free C3A clonal cell line and methods for generating the same are provided. The C3A cell line has a reduced doubling time in serum-free medium compared to a corresponding C3A cell line from which it is derived. Methods using the cells of the serum-free C3A clonal cell line for the production, expression and recovery of harvestable polypeptides, screening compounds for metabolic activity, studying enteric disease and for use in a bio-artificial liver device are also provided.
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: May 6, 2014
    Assignee: Vital Therapies, Inc.
    Inventors: Dennis Triglia, Anthony Purchio
  • C3A Serum-Free Clonal Cell Line and Methods of Use
    Publication number: 20090035805
    Abstract: A serum-free C3A clonal cell line and methods for generating the same are provided. The C3A cell line has a reduced doubling time in serum-free medium compared to a corresponding C3A cell line from which it is derived. Methods using the cells of the serum-free C3A clonal cell line for the production, expression and recovery of harvestable polypeptides, screening compounds for metabolic activity, studying enteric disease and for use in a bio-artificial liver device are also provided.
    Type: Application
    Filed: June 20, 2008
    Publication date: February 5, 2009
    Inventors: Dennis Triglia, Anthony Purchio
  • C3A serum-free clonal cell line and methods of use
    Patent number: 7390651
    Abstract: A serum-free C3A clonal cell line and methods for generating the same are provided. The C3A cell line has a reduced doubling time in serum-free medium compared to a corresponding C3A cell line from which it is derived. Methods using the cells of the serum-free C3A clonal cell line for the production, expression and recovery of harvestable polypeptides, screening compounds for metabolic activity, studying enteric disease and for use in a bio-artificial liver device are also provided.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: June 24, 2008
    Assignee: Vital Therapies, Inc.
    Inventors: Dennis Triglia, Anthony Purchio
  • C3A serum-free clonal cell line and methods of use
    Publication number: 20040166562
    Abstract: A serum-free C3A clonal cell line and methods for generating the same are provided. The C3A cell line has a reduced doubling time in serum-free medium compared to a corresponding C3A cell line from which it is derived. Methods using the cells of the serum-free C3A clonal cell line for the production, expression and recovery of harvestable polypeptides, screening compounds for metabolic activity, studying enteric disease and for use in a bio-artificial liver device are also provided.
    Type: Application
    Filed: November 25, 2003
    Publication date: August 26, 2004
    Inventors: Dennis Triglia, Anthony Purchio
  • Clonal cells and cell lines derived from C3A cells and methods of making and using them
    Patent number: 6653105
    Abstract: A serum-free C3A clonal cell line and methods for generating the same are provided. The C3A cell line has a reduced doubling time in serum-free medium compared to a corresponding C3A cell line from which it is derived. Methods using the cells of the serum-free C3A clonal cell line for the production, expression and recovery of harvestable polypeptides, screening compounds for metabolic activity, studying enteric disease and for use in a bio-artificial liver device are also provided.
    Type: Grant
    Filed: February 11, 1998
    Date of Patent: November 25, 2003
    Assignee: Vitagen, Inc.
    Inventors: Dennis Triglia, Anthony Purchio